Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Innovations in Genicular Outcomes Registry

Key facts

Who runs it
Pacira Pharmaceuticals, Inc
Where
Alexandria, Asheville, Baltimore, Bethesda, DeLand, DuBois, Garden City, Germantown, Irvine, Jersey City, Los Angeles, New Hartford, New Orleans, North Chelmsford, Omaha, Phoenix, Salt Lake City, State College, and Tulsa, United StatesSee the 19 sites
Trial code
Status
Recruiting
People taking part
10,000 people, planned
Started
23 Sept 2021
Expected to end
30 Dec 2033
Type of study
Observational
Treatments tested
  • Treatment for Knee OA
Record updated
23 July 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening
  • Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator
  • Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application

Who cannot take part

  • Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol
  • Planning to have a surgery other than on the target knee

Where in United States

  • MidState Orthopedics and Sports MedicineAlexandria, United StatesContact: David Rogenmoser, DO (principal investigator)Taking people
  • Blue Nine SystemsAsheville, United StatesContact: Kate Fasel, BSNNo longer taking part
  • Sinai Hospital of BaltimoreBaltimore, United StatesContact: Michael Mont, MD (principal investigator)Taking people
  • Henry M Jackson Foundation for the Advancement of Military Medicine/Walter Reed National Military Medical CenterBethesda, United StatesContact: Kate Fasel, BSNNo longer taking part
  • Florida Orthopaedic AssociatesDeLand, United StatesContact: Mark Hollmann, MD (principal investigator)Taking people
  • Penn Highlands DuBoisDuBois, United StatesContact: Christopher Varacallo, DO (principal investigator)Taking people
  • Northwell HealthGarden City, United StatesContact: Giles Scuderi, MD (principal investigator)Taking people
  • Campbell ClinicGermantown, United StatesContact: William Mihalko, MD (principal investigator)Taking people
  • Orthopedic Education and Research Institute of So Ca (Hoag)Irvine, United StatesContact: Adam Rivadeneyra, MD (principal investigator)Taking people
  • Jersey City Medical CenterJersey City, United StatesContact: Kate Fasel, BSNNo longer taking part
  • Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Andrew Spitzer, MD (principal investigator)Taking people
  • Genesee Orthopedics and Plastic Surgery (St. Elizabeth Med Center/ Apex Surgical Center)New Hartford, United StatesContact: Kate Fasel, BSNNo longer taking part
  • Louisiana State University /OchsnerNew Orleans, United StatesContact: Vinod Dasa, MD (principal investigator)Taking people
  • Orthopaedic Surgical AssociatesNorth Chelmsford, United StatesContact: Scott Sigman, MD (principal investigator)Taking people
  • OrthoNebraska ClinicsOmaha, United StatesContact: Joshua Urban, MD (principal investigator)Taking people
  • The MORE FoundationPhoenix, United StatesContact: Anuj Daftari, MD (principal investigator)Taking people
  • University of UtahSalt Lake City, United StatesContact: Alexandra Fogarty, MD (principal investigator)Taking people
  • University Orthopedics CenterState College, United StatesContact: Thomas Ellis, DO (principal investigator)Taking people
  • Oklahoma Surgical HospitalTulsa, United StatesContact: Sarat Kunapuli, DO (principal investigator)Taking people

About the trial

What the trial wants to find out

The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs [NSAIDs]).

The group in the trial

  • All participants

    Eligible and enrolled subjects with knee OA pain who require treatment on the target knee as a part of pain management.

    Treatment: Treatment for Knee OA

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
23 July 2026